Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
ASX Health Stocks: Botanix to get FDA approval by June; 4DMedical partners with global player, Philips
Health & Biotech
The next Neuren? These ASX biotech stocks have pending FDA catalysts in 2024
Health & Biotech
Weed Week: Blow to cannabis as Thailand backpedals on weed law; and recent ASX pot stock winners
Health & Biotech
ASX Health Stocks: UBI’s sales to exceed $1m, Pacific Smiles rejects takeover offer
Experts
Dr Boreham’s Crucible: Excessive sweater? Botanix is here to get you fit for public consumption again
Health & Biotech
Weed Week: Cannabis boom a ‘matter of when, not if’; and NSW to allow residents to grow pot
Health & Biotech
ASX Health Stocks: Compumedics granted FDA clearance; Botanix receives FDA feedback
News
Market Highlights: Tesla unveils Cybertruck, RBA to pause, and 5 small caps to watch today
News
Closing Bell: Material losses and profit taking at home ahead of Thanksgiving in New York
Health & Biotech
ScoPo’s Powerplays: Who fancies a ‘MedWalk intervention’? Oh, and ASX healthcare stocks can’t catch a break
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
Health & Biotech
ASX Health Stocks: Botanix Pharma plunges 25pc after FDA requests this minor change
News
Top 10 at 11: It’s all about manganese, lithium and an overall sense of wellbeing and happiness
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Catch up footy leaves benchmark nibbling at parity for second straight session
Health & Biotech
ScoPo’s Powerplays: Who remembers that time they died? Oh, and Ramsay Healthcare cops credit downgrade
Health & Biotech